Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Complete results of Phase 1/2 CHRYSALIS trial of gilteritinib in patients with Relapsed/Refractory AML to be presented during Oral Session on Dec. 5 - NORTHBROOK, Ill., Nov. 17, 2016 /PRNewswire/ --
Doug Noland will serve as Executive Director NORTHBROOK, Ill., Nov. 2, 2016 /PRNewswire/ -- Astellas today announced the creation of a new department in the Americas that will formally build on...
Read more about Astellas Establishes Patient Experience Organization in the Americas
-Social Shares of #OrganDonor Support $5 Contribution from Astellas to World Transplant Games Federation, up to $175,000 USD- NORTHBROOK, Ill. and RICHMOND, Va., Oct. 27, 2016 /PRNewswire/ -- At...
NORTHBROOK, Ill., Oct. 26, 2016 /PRNewswire/ -- Astellas USA Foundation has named Moyra Knight as president, transitioning from Jeffrey A. Winton, outgoing Astellas USA Foundation president....
Read more about Astellas USA Foundation names Moyra Knight as President
Three C3 Prize winners awarded a total of $100,000 in grants and a membership to MATTER NORTHBROOK, Ill., Oct. 11, 2016 /PRNewswire/ -- Astellas Oncology announced the three winners of the...
Follow U.S. news
